Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
- PMID: 30060089
- DOI: 10.1093/annonc/mdy261
Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
Comment on
-
Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma.Ann Oncol. 2018 Mar 1;29(3):700-706. doi: 10.1093/annonc/mdx765. Ann Oncol. 2018. PMID: 29216356 Free PMC article. Clinical Trial.
Similar articles
-
Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients.Mol Med. 2019 Apr 27;25(1):15. doi: 10.1186/s10020-019-0082-5. Mol Med. 2019. PMID: 31029076 Free PMC article.
-
Combining plasma-based biosources to predict treatment response in NSCLC patients.Ann Oncol. 2018 Sep 1;29(9):2022. doi: 10.1093/annonc/mdy246. Ann Oncol. 2018. PMID: 30010765 No abstract available.
-
The detection and significance of EGFR and BRAF in cell-free DNA of peripheral blood in NSCLC.Oncotarget. 2017 Jul 25;8(30):49773-49782. doi: 10.18632/oncotarget.17937. Oncotarget. 2017. PMID: 28572536 Free PMC article.
-
Prognostic value of EGFR and KRAS in circulating tumor DNA in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis.Oncotarget. 2017 May 16;8(20):33922-33932. doi: 10.18632/oncotarget.15412. Oncotarget. 2017. PMID: 28430611 Free PMC article. Review.
-
Circulating tumour DNA in EGFR-mutant non-small-cell lung cancer.Curr Oncol. 2018 Jun;25(Suppl 1):S38-S44. doi: 10.3747/co.25.3761. Epub 2018 Jun 13. Curr Oncol. 2018. PMID: 29910646 Free PMC article. Review.
Cited by
-
Current Knowledge and Future Perspectives of Exosomes as Nanocarriers in Diagnosis and Treatment of Diseases.Int J Nanomedicine. 2023 Aug 21;18:4751-4778. doi: 10.2147/IJN.S417422. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37635911 Free PMC article. Review.
-
The Implication of Liquid Biopsy in the Non-small Cell Lung Cancer: Potential and Expectation.Methods Mol Biol. 2023;2695:145-163. doi: 10.1007/978-1-0716-3346-5_10. Methods Mol Biol. 2023. PMID: 37450117 Review.
-
Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era.Med Sci (Basel). 2023 Jan 4;11(1):8. doi: 10.3390/medsci11010008. Med Sci (Basel). 2023. PMID: 36649045 Free PMC article. Review.
-
Detection of circulating KRAS mutant DNA in extracellular vesicles using droplet digital PCR in patients with colon cancer.Front Oncol. 2022 Dec 15;12:1067210. doi: 10.3389/fonc.2022.1067210. eCollection 2022. Front Oncol. 2022. PMID: 36591510 Free PMC article.
-
Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer.Front Oncol. 2022 Oct 27;12:1027664. doi: 10.3389/fonc.2022.1027664. eCollection 2022. Front Oncol. 2022. PMID: 36387176 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
